Safety and efficacy of Myobloc® (botulinum toxin type B) for sialorrhea in Parkinson's disease (PD) patients

被引：0
|
作者：
Pappert, Eric [1 ]
Reinhard, Sharon [1 ]
Salazar-Grueso, Edgar [1 ]
机构：
[1] Solstice Neurosci Inc, Malvern, PA USA
来源：
TOXICON | 2008年 / 51卷
关键词：
botulinum toxin B; sialorrhea;
D O I：
10.1016/j.toxicon.2008.04.154
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
152
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [31] The effectiveness and safety of botulinum toxin injections for the treatment of sialorrhea with Parkinson's disease: a systematic review and meta-analysis
    Chun-Lan Yang
    Jia-Peng Huang
    Ying-chao Tan
    Ting-ting Wang
    Han Zhang
    Yun Qu
    BMC Pharmacology and Toxicology, 24
  • [32] Efficacy and safety of botulinum toxin in the treatment of sialorrhea in children with neurological disorders
    Garcia Ron, A.
    Miranda, M. C.
    Garriga Braun, C.
    Jensen Veron, J.
    Torrens Martinez, J.
    Diez Hanbino, M. P.
    ANALES DE PEDIATRIA, 2012, 77 (04): : 289 - 291
  • [33] The effectiveness and safety of botulinum toxin injections for the treatment of sialorrhea with Parkinson's disease: a systematic review and meta-analysis
    Yang, Chun-Lan
    Huang, Jia-Peng
    Tan, Ying-chao
    Wang, Ting-ting
    Zhang, Han
    Qu, Yun
    BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
  • [34] Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines
    Ramirez, AL
    Reeck, J
    Maas, CS
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2002, 126 (05) : 459 - 467
  • [35] Botulinum toxin type B for sialorrhea in children with cerebral palsy
    Reddihough, Dinah
    Graham, H. Kerr
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2011, 53 (06): : 488 - 489
  • [36] Botulinum toxin type B (Myobloc™) for the treatment of hemifacial spasm and blepharospasm
    Struck, LK
    MOVEMENT DISORDERS, 2002, 17 : S278 - S278
  • [37] Stability of Myobloc™/Neurobloc™ (botulinum toxin type B) in preserved saline
    Setler, P
    Burke, D
    Callaway, J
    Wang, C
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R40 - R40
  • [38] A review of adverse events associated with botulinum toxin type B (Myobloc®)
    Royal, MA
    Pappert, EJ
    Leong, MS
    NEUROLOGY, 2006, 66 (05) : 291 - 291
  • [39] A double-blind, randomised, placebo-controlled study to evaluate efficacy and safety of botulinum toxin type b (myobloc/neurobloc) and botulinum toxin type A (dysport) for the treatment of spastic paraparesis
    Mancini, F
    Moglia, A
    Allena, M
    Sandrini, G
    Nappi, G
    Pacchetti, C
    MOVEMENT DISORDERS, 2004, 19 : S127 - S127
  • [40] Botulinum toxin injections for sialorrhea in Parkinson's disease and parkinsonism: 5 years follow up
    Borrue, C.
    Jimeno, C.
    MOVEMENT DISORDERS, 2021, 36 : S133 - S133
12345